Literature DB >> 11136712

Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia.

P Q Thomas1, M T Dattani, J M Brickman, D McNay, G Warne, M Zacharin, F Cameron, J Hurst, K Woods, D Dunger, R Stanhope, S Forrest, I C Robinson, R S Beddington.   

Abstract

We have previously shown that familial septo-optic dysplasia (SOD), a syndromic form of congenital hypopituitarism involving optic nerve hypoplasia and agenesis of midline brain structures, is associated with homozygosity for an inactivating mutation in the homeobox gene HESX1/Hesx1 in man and mouse. However, as most SOD/congenital hypopituitarism occurs sporadically, the possible contribution of HESX1 mutations to the aetiology of these cases is presently unclear. Interestingly, a small proportion of mice heterozygous for the Hesx1 null allele show a milder SOD phenocopy, implying that heterozygous mutations in human HESX1 could underlie some cases of congenital pituitary hypoplasia with or without midline defects. Accordingly, we have now scanned for HESX1 mutations in 228 patients with a broad spectrum of congenital pituitary defects, ranging in severity from isolated growth hormone deficiency to SOD with panhypopituitarism. Three different heterozygous missense mutations were detected in individuals with relatively mild pituitary hypoplasia or SOD, which display incomplete penetrance and variable phenotype amongst heterozygous family members. Gel shift analysis of the HESX1-S170L mutant protein, which is encoded by the C509T mutated allele, indicated that a significant reduction in relative DNA binding activity results from this mutation. Segregation analysis of a haplotype spanning 6.1 cM, which contains the HESX1 locus, indicated that only one HESX1 mutation was present in the families containing the C509T and A541G mutations. These results demonstrate that some sporadic cases of the more common mild forms of pituitary hypoplasia have a genetic basis, resulting from heterozygous mutation of the HESX1 gene.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11136712     DOI: 10.1093/hmg/10.1.39

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  60 in total

Review 1.  HESX1 and Septo-Optic Dysplasia.

Authors:  Mehul Tulsidas Dattani; Iain Caf Robinson
Journal:  Rev Endocr Metab Disord       Date:  2002-12       Impact factor: 6.514

Review 2.  From panhypopituitarism to combined pituitary deficiencies: do we need the anterior pituitary?

Authors:  Catherine Carrière; Anatoli Gleiberman; Chijen R Lin; Michael G Rosenfeld
Journal:  Rev Endocr Metab Disord       Date:  2004-03       Impact factor: 6.514

Review 3.  Growth hormone and IGF-1.

Authors:  Roberto Salvatori
Journal:  Rev Endocr Metab Disord       Date:  2004-03       Impact factor: 6.514

4.  Pituitary development and physiology.

Authors:  Clement C Cheung; Robert H Lustig
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

Review 5.  Prenatal determinants of optic nerve hypoplasia: review of suggested correlates and future focus.

Authors:  Pamela Garcia-Filion; Mark Borchert
Journal:  Surv Ophthalmol       Date:  2013 Nov-Dec       Impact factor: 6.048

6.  Congenital abnormalities of cranial nerve development: overview, molecular mechanisms, and further evidence of heterogeneity and complexity of syndromes with congenital limitation of eye movements.

Authors:  Elias I Traboulsi
Journal:  Trans Am Ophthalmol Soc       Date:  2004

Review 7.  Molecular defects in the growth hormone-IGF axis.

Authors:  Joyce Lee; Ram K Menon
Journal:  Indian J Pediatr       Date:  2005-02       Impact factor: 1.967

8.  A novel SNP of the Hesx1 gene in bovine and its associations with average daily gain.

Authors:  Xinsheng Lai; Xianyong Lan; Hong Chen; Xinlei Wang; Keyi Wang; Mou Wang; Hui Yu; Miao Zhao
Journal:  Mol Biol Rep       Date:  2008-10-14       Impact factor: 2.316

9.  Heterozygous mutation of HESX1 causing hypopituitarism and multiple anatomical malformations without features of septo-optic dysplasia.

Authors:  G Corneli; D Vivenza; F Prodam; G Di Dio; A Vottero; A Rapa; S Bellone; S Bernasconi; G Bona
Journal:  J Endocrinol Invest       Date:  2008-08       Impact factor: 4.256

10.  Abnormal cognitive function in treated congenital hypopituitarism.

Authors:  K Brown; J Rodgers; H Johnstone; W Adams; M Clarke; M Gibson; T Cheetham
Journal:  Arch Dis Child       Date:  2004-09       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.